Long-term T-cell-mediated immunity to epstein-barr virus in man. IV. Development of T-cell memory in convalescent infectious mononucleosis patients
- 15 January 1980
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 25 (1), 59-65
- https://doi.org/10.1002/ijc.2910250108
Abstract
Under appropriate culture conditions, EB virus infection of lymphocytes from seropositive donors leads to regression of transformation, and this was shown previously to be due to activation in a secondary immune response of T lymphocytes inhibitory for the autologous lymphoblastoid cell line. Regression can be quantified by determining the number of cells required for its expression. To investigate the development of memory T cells with EB-virus specificity in the primary infection, a comparison was made of the capacity for regression of lymphocytes from 16 cases of infectious mononucleosis (IM) and 13 normal donors. With 9 normal seropositive donors a mean lymphocyte concentration of 4.6 × 105/ml was required to achieve 50% regression. In contrast, with 8 cases of IM tested within I week of onset, a much higher mean lymphocyte concentration (3.7 × 106/ml) was necessary. Six of these IM cases, and another not tested in the first week, were tested on several occasions between 5 and 23 weeks after onset, and showed a slight reduction in the mean cell concentration required for regression (1.5 × 1O6/ml). Six additional IM cases were tested 23–83 weeks after onset by which time the cell concentration required for 50% regression (mean = 4.5 × 1O5/ml) had reached the level shown by normal seropositive donors. Regression did not occur with lymphocytes from seronegative donors, even at the highest cell concentration. Recombination cultures of T-cell-de-pleted and T-cell-enriched lymphocyte populations from 3 IM cases in ratios of 1:7 to 7:1 showed that the failure of regression in acute IM was not due simply to lack of sufficient numbers of T cells. The results indicate that EB-virus-specific memory T-cell activity as detected by the regression test is absent in the acute phase of IM, becomes evident at low levels 5–23 weeks after onset, and reaches a maximum after about 6 months.This publication has 28 references indexed in Scilit:
- Long‐term T‐cell‐mediated immunity to Epstein‐Barr virus in man. III. Activation of cytotoxic T cells in virus‐infected leukocyte culturesInternational Journal of Cancer, 1979
- Long‐term T‐cell‐mediated immunity to epstein‐barr virus in man. I. Complete regression of virus‐induced transformation in cultures of seropositive donor leukocytesInternational Journal of Cancer, 1978
- EBV-related cytotoxicity of Fc receptor negative T lymphocytes separated from the blood of infectious mononucleosis patientsCancer Letters, 1978
- Lymphocyte responses to ebv-associated antigens in infectious mononucleosis, and hodgkin's and non-hodgkin's lymphoma patients, with the leukocyte adherence inhibition assayInternational Journal of Cancer, 1977
- Depression of Cell-Mediated Immunity during Acute Infectious MononucleosisNew England Journal of Medicine, 1974
- The nature of the atypical lymphocyte in infectious mononucleosisClinical Immunology and Immunopathology, 1974
- T- and B-Cells in Peripheral Blood during Infectious MononucleosisThe Journal of Infectious Diseases, 1974
- Assay of the Infectivity of Epstein-Barr Virus by Transformation of Human Leucocytes in vitroJournal of General Virology, 1972
- Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis.Proceedings of the National Academy of Sciences, 1968
- The Glomerular Permeability Determined by Dextran Clearance Using Sephadex Gel FiltrationScandinavian Journal of Clinical and Laboratory Investigation, 1968